4 October 2024
Versarien Plc
("Versarien", the "Company" or the "Group")
Corporate Update
Versarien Plc (AIM: VRS), the advanced materials engineering group, is pleased to provide the following update on developments at the Company as pipelines continue to improve following the appointment of Dr Stephen Hodge as CEO just over a year ago. As at 1 October 2023 the pipeline of opportunities stood at
The Company's strategy continues to be the development of advanced materials, particularly graphene and related materials, using Versarien's manufacturing-light operations, and the licensing of the Company's technology.
Sector updates
The Company's focus sectors continue to be construction and leisure, however, it maintains the ability to be agile enough to re-align to other sectors that form part of Versarien's commercial pipelines. These include sectors that can utilise the Company's families of functional 2D inks (Graphinks™) and graphene-based thermoplastic, thermoset and elastomer compounds and masterbatches (Polygrene™).
Construction
Following the placing to raise gross proceeds of
In August, Versarien signed its first significant 3D construction printing ("3DCP") contract with Building For Humanity CIC, for their flagship Charter Street project, in
Versarien has also delivered a feasibility study for a high-profile cultural project, which is to be built using 3DCP technology. The next design phase of the project is expected to commence by the end of the year.
Although it is unlikely that graphene will feature as part of these two projects, the Company announced on 1 October 2024 that it had entered into a 12 month commercially funded project with Balfour Beatty, one of the
This month, Versarien will be exhibiting at two major construction industry events hosted at the NEC,
At Highways
Whilst the Company is focused on being a manufacturing-light operation, developing new talent in-house remains a priority. Versarien was pleased to recently become an 'Employee Partner' with AccXel Construction School, local to Longhope, and has recently taken on its first Site Supervision Apprentice.
Leisure
The Company has recently generated Graphene-Wear™ ink sales to customers in
Versarien's Graphene-Wear™ footwear outsole rubber compounds have also been further improved for Flux Footwear, in the
Technology Licencing
In March 2024, Versarien entered into a manufacturing licence agreement and a know-how licence and technical assistance agreement with Montana Química LTDA ("
The Company is currently engaged in discussions with various other parties, in other geographical locations, who are keen to distribute Versarien's advanced materials and are interested to localise manufacturing using Versarien's technologies and know-how.
R&D Updates
The Group's R&D activity continues to progress with
Versarien is keeping abreast of changes to the future European advanced materials ecosystem driven by The Innovative Advanced Materials Initiative ("IAM-I") by becoming an Industry Member. IAM-I has announced energy, mobility, construction and electronics as the initial four strategic research and innovation priority areas. This month, Dr Hodge will attend Graphene Week 2024 in
Cambridge Graphene Limited ("CGL")
CGL staff continue to support ongoing work in the Digital Roads of the Future project at the University of
2-DTech Limited ("2DT")
2DT is involved in the Horizon Europe project 'ICARE' where it is playing a key role by developing protocols and supplying graphene materials used in products like mortars, concretes (including 3D printable materials), and rubber goods (tyres, footwear) in order to support the understanding of graphene's life cycle and the potential exposure routes and toxicology to end users. This important project aims to create new systems that assess and predict the impacts of nanomaterials on brain health, preventing neurotoxicity.
2DT funded PhD student projects also continue at WMG, University of
Gnanomat ("GNA")
GNA has been making significant progress with the support of the ICEX Trade and Investment grant, awarded in September 2023. This includes launching a new business line in the field of functional printing, offering a powerful avenue to bring its products to the market. GNA has established in-house manufacturing capabilities to supply large volumes of functional inks (in the range of one metric tonne per year). Initially, it has focused on developing new products for printed electronics, while also expanding into other applications such as electromagnetic interference (EMI) shielding, sensing, and security. During the development of this new business line, new know-how has led to the filing of a new patent.
GNA is actively seeking strategic collaborations with major international companies to accelerate the commercialisation of its products across various sectors. The GNA team has established co-development contracts with IRPC in
Versarien will maintain its CVD graphene activity in
Commenting, Dr Stephen Hodge, Versarien CEO, stated: "I am delighted to report that Versarien is continuing to make significant strides in its commercial endeavours, building on our strong foundation of innovation and collaboration. Over the past year, we have seen encouraging growth across all our key markets, particularly construction. We are achieving our milestones as laid out in our turnaround strategy with the disposal of AAC Cyroma and sale of our CVD graphene assets. I am also optimistic that we will be able to progress the sale of Total Carbide.
"Our strategic partnerships with large
For further information please contact:
Versarien Stephen Hodge, Chief Executive Officer Chris Leigh, Chief Financial Officer
|
c/o IFC |
SP Angel Corporate Finance (Nominated Adviser and Broker) Matthew Johnson, Adam Cowl
|
+44 (0)20 3470 0470
|
IFC Advisory Limited (Financial PR and Investor Relations) Tim Metcalfe, Zach Cohen |
+44 (0) 20 3934 6630 |
For further information please see: http://www.versarien.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.